Implementation of subjective cognitive decline criteria in research studies
Jose L Molinuevo, Laura A Rabin, Rebecca Amariglio, Rachel Buckley, Bruno Dubois, Kathryn A Ellis, Michael Ewers, Harald Hampel, Stefan Kloeppel, Lorena Rami, Barry Reisberg, Andrew J Saykin, Sietske Sikkes, Colette M Smart, Beth E Snitz, Reisa Sperling, Wiesje M van der Flier, Michael Wagner, Frank Jessen
Alzheimer's & Dementia | ELSEVIER SCIENCE INC | Published : 2017
Awarded by National Institute of Health Carlos III (ISCIII)
Awarded by European Commission (ERC)
Awarded by Alzheimer's Forschung Initiative (AFI)
Awarded by program "Investissements d'avenir"
Awarded by US Department of Health and Human Services (DHHS)
Awarded by US National Institute on Aging-National Institutes of Health
This work has received support from the project "Subjective cognitive decline in preclinical Alzheimer's Disease: European initiative on harmonization and on a lifestyle based prevention strategy"-EU Joint Programme-Neurodegenerative Disease Research (JPND); in Spain through the National Institute of Health Carlos III (ISCIII) (AC14/00014) and European Regional Development Fund (ERDF): "a way to build Europe." JLM research at the BBRC receives founding from "la Caixa" Foundation. For Dr Ewers, the research was funded by grants of the LMUexcellent Initiative and the European Commission (ERC, PCIG12-GA-2012-334259), Alzheimer's Forschung Initiative (AFI, DE-15035). HH is supported by the AXA Research Fund, the Fondation Universite Pierre et Marie Curie, and the Fondation pour la Recherche sur Alzheimer, Paris, France. The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06. Ce travail a beneficie d'une aide de l'Etat "Investissements d' avenir" ANR-10-IAIHU-06. Dr Barry Reisberg's work was supported in part by US Department of Health and Human Services (DHHS) grants AG03051 and AG08051, from the National Institute on Aging of the US National Institutes of Health; by grants from Mr Zachary Fisher and Mrs Elizabeth M. Fisher and from the Fisher Center for Alzheimer's Research Foundation; by the Hagedorn Fund, the Stringer Foundation, the Louis J. Kay and June E. Kay Foundation; and donations from Mrs Miriam Glaubach and Dr. Felix Glaubach and a Clinical Researcher Development Fund of the New York University School of Medicine. The Global Deterioration Scale and the Brief Cognitive Scale noted in this publication are instruments developed and copyrighted by Barry Reisberg, MD. Dr Snitz is supported by the US National Institute on Aging-National Institutes of Health (K23AG038479). Research of the VUmc Alzheimer center is part of the neurodegeneration research program of the Neuroscience Campus Amsterdam. The VUmc Alzheimer Center is supported by Stichting Alzheimer Nederland and Stichting VUmc fonds. Wiesje van der Flier is recipient of a research grant on the topic of SCD from the Gieskes-Strijbis fonds.